Literature DB >> 12361877

Ototoxic side-effects of the I(Ks)-channel blocker HMR1556.

Rainer Hartmann1, Uwe Gerlach, Rainer Klinke.   

Abstract

The inhibitor of I(Ks)-channels, HMR1556, a potentially antiarrhythmic drug, might possess ototoxic side-effects. The I(Ks)-channels are not only expressed in the heart but also in the stria vascularis of the inner ear and in the dark cells of the vestibular organ. Therefore possible effects of HMR1556 on hearing were studied in cats. Thresholds and intensity function of the cochlear action potential (CAP) were used as criteria. In addition to effects of the drug on heart rate and ECG, a substantial elevation of hearing thresholds and a shift in CAP intensity functions were observed. There was a clear dose-effect relationship. The hearing impairment observed showed a tendency for recovery. It is concluded that inhibitors of I(Ks)-channels may generally exert ototoxic effects provided they can reach the cochlear spaces.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361877     DOI: 10.1016/s0378-5955(02)00576-2

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  2 in total

1.  Endogenous KCNE subunits govern Kv2.1 K+ channel activation kinetics in Xenopus oocyte studies.

Authors:  Earl Gordon; Torsten K Roepke; Geoffrey W Abbott
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

2.  Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.

Authors:  Courtney M Campbell; Jonathan D Campbell; Christopher H Thompson; Eleonora Savio Galimberti; Dawood Darbar; Carlos G Vanoye; Alfred L George
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-09-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.